Izuma Nakayama
0000-0003-4987-1934
Publication & Citation Trends
Publications
0 total
An open-label phase Ib/II study of trastuzumab deruxtecan combined with nivolumab and CAPOX for HER2-low gastroesophageal adenocarcinoma
Cited by 0
Semantic Scholar
770P Impact of ctDNA testing on decision-making for adjuvant chemotherapy in colorectal cancer: A prospective multicenter study
Cited by 0
Semantic Scholar
1015eTiP Beamion BCGC-1: A phase Ib/II, randomized, open-label, multicenter trial of oral zongertinib, alone or in combination, for the treatment of advanced HER2-positive metastatic breast cancer (mBC) and metastatic gastric, gastroesophageal junction, or esophageal adenocarcinoma (mGEAC)
Cited by 0
Semantic Scholar
Clinical implementation of simultaneous multiple biomarkers testing for metastatic or recurrent gastroesophageal adenocarcinoma: a single-institutional experience
Cited by 12
Semantic Scholar
Real-world outcomes of trifluridine/tipiracil for heavily pretreated patients with advanced gastric cancer OA
Cited by 0
Semantic Scholar
500TiP An open label phase Ib/II study of trastuzumab deruxtecan (T-DXd) in combination with nivolumab and CAPOX for patients with HER2-low expressing gastroesophageal adenocarcinoma (EPOC2203)
Cited by 4
Semantic Scholar
1465P Potential impact of APC mutation on survival via immune evasion through WNT signaling activation in HER2-positive gastric cancer treated with trastuzumab (tmab), nivolumab (nivo), and chemotherapy
Cited by 0
Semantic Scholar
Safety and efficacy of first-line nivolumab plus chemotherapy for HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: real-world data analysis
Cited by 4
Semantic Scholar
Research Topics
Gastric Cancer Management and Outcomes
(123)
Colorectal Cancer Treatments and Studies
(78)
Gastrointestinal Tumor Research and Treatment
(35)
HER2/EGFR in Cancer Research
(33)
Metastasis and carcinoma case studies
(25)
Affiliations
Nihon University
University of California, Los Angeles
Kyorin University
Tohoku University
Cancer Institute (WIA)